GlassScriptPhysician profile
Satin S Patel
NPI 1437359007
$32,455.49
in general payments reported to CMS, 2019-2025
15 companies · $640 in 2025
The $640 reported for 2025 was more than what 90% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $4,863 · 2021: $409 · 2022: $415 · 2023: $634 · 2024: $527 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,800.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18,015.34 | 2019-2025 | Aptima |
| Galen US INC | $10,406.46 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $1,554.30 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $782.80 | 2019-2025 | Stripper |
| Gen-Probe Sales & Service, INC. | $613.04 | 2019 | |
| Emd Serono, INC. | $456.80 | 2019-2024 | |
| Organon LLC | $193.08 | 2021-2025 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Ferring Pharmaceuticals As | $126.88 | 2022 | |
| Gynesonics, INC. | $96.64 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $68.43 | 2020-2021 | |
| Myriad Women'S Health, INC. | $52.24 | 2023 | Genesight |
| Meditrina | $31.46 | 2025 | |
| Boston Scientific Corporation | $22.24 | 2023 | Watchman Access System |
| Virtus Pharmaceuticals LLC | $20.22 | 2022 | |
| Minerva Surgical, INC | $15.56 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.